Latest Breaking News On - Thestreet vaccine stocks checkup - Page 1 : comparemela.com

Vaccine Stocks Checkup: Johnson & Johnson Is Rising TheStreet 1 hr ago © TheStreet Vaccine Stocks Checkup: Johnson & Johnson Is Rising Johnson & Johnson posted stronger-than-expected first-quarter earnings and boosted its full-year earnings forecast as sales from medical devices and pharmaceuticals recorded solid post-pandemic gains. Vaccine sales, Johnson & Johnson said, reached $100 million. Popular Searches The company said adjusted earnings for the three months ending in March came in at $2.59 cents per share, up 12.6% from the same period last year and well ahead of the Street consensus forecast of $2.34 per share. Group revenues, Johnson & Johnson said, rose 7.9% to $22.3 billion, again besting analysts estimates of a $22 billion tally.

Bayview
Western-cape
South-africa
Germany
Norway
Iceland
United-kingdom
White-house
District-of-columbia
United-states
Brazil
Cambridge